$0.45 Earnings Per Share Expected for Phibro Animal Health (PAHC) This Quarter

Brokerages expect Phibro Animal Health (NASDAQ:PAHC) to announce earnings of $0.45 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Phibro Animal Health’s earnings. The highest EPS estimate is $0.45 and the lowest is $0.44. Phibro Animal Health reported earnings per share of $0.39 in the same quarter last year, which would suggest a positive year over year growth rate of 15.4%. The company is scheduled to issue its next quarterly earnings results on Wednesday, August 29th.

According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.71 per share for the current fiscal year, with EPS estimates ranging from $1.70 to $1.73. For the next fiscal year, analysts anticipate that the firm will report earnings of $1.89 per share, with EPS estimates ranging from $1.86 to $1.90. Zacks’ EPS averages are a mean average based on a survey of research firms that cover Phibro Animal Health.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 7th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.02. Phibro Animal Health had a net margin of 7.24% and a return on equity of 41.29%. The company had revenue of $209.00 million for the quarter, compared to the consensus estimate of $203.03 million. During the same period in the prior year, the firm posted $0.37 EPS. Phibro Animal Health’s revenue for the quarter was up 10.0% on a year-over-year basis.

Several analysts recently commented on PAHC shares. BidaskClub downgraded shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research report on Friday, January 26th. Credit Suisse Group upped their target price on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, February 6th. Morgan Stanley upped their target price on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research note on Wednesday, February 7th. Zacks Investment Research upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research note on Thursday, February 8th. Finally, ValuEngine upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $38.80.

In other Phibro Animal Health news, major shareholder Bfi Co., Llc sold 12,000 shares of the company’s stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $40.12, for a total transaction of $481,440.00. Following the transaction, the insider now owns 24,000 shares in the company, valued at approximately $962,880. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $35.62, for a total transaction of $356,200.00. Following the transaction, the insider now owns 10,000 shares in the company, valued at approximately $356,200. The disclosure for this sale can be found here. Insiders have sold a total of 276,056 shares of company stock worth $10,495,260 in the last 90 days. Company insiders own 51.88% of the company’s stock.

Large investors have recently modified their holdings of the company. Goldman Sachs Group Inc. lifted its stake in shares of Phibro Animal Health by 17.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock worth $15,959,000 after purchasing an additional 69,063 shares during the period. California Public Employees Retirement System lifted its stake in shares of Phibro Animal Health by 9.5% in the 3rd quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock worth $1,667,000 after purchasing an additional 3,894 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Phibro Animal Health by 37.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock worth $8,159,000 after purchasing an additional 66,300 shares during the period. Investors Research Corp bought a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $433,000. Finally, Crossmark Global Holdings Inc. bought a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $253,000. Hedge funds and other institutional investors own 48.25% of the company’s stock.

PAHC stock traded down $0.20 during trading on Friday, hitting $44.05. 2,969 shares of the stock traded hands, compared to its average volume of 100,831. Phibro Animal Health has a 1 year low of $43.90 and a 1 year high of $45.17. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 29.30, a price-to-earnings-growth ratio of 2.99 and a beta of 0.92. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.75 and a current ratio of 3.12.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 27th. Shareholders of record on Wednesday, June 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 0.91%. The ex-dividend date is Tuesday, June 5th. Phibro Animal Health’s dividend payout ratio is currently 26.49%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply